117 results
Page 4 of 6
SD
EX-1.01
zebrl 55ywgv
28 May 21
Conflict minerals disclosure
4:41pm
8-K
EX-99.1
1aovq2yxchqc4on
10 May 21
Pulse Biosciences Reports First Quarter 2021 Financial Results
4:23pm
8-K
EX-10.1
itk8 6ckd4qgr7uwwr6a
11 Mar 21
Entry into a Material Definitive Agreement
4:32pm
8-K
EX-99.1
8c91y5
22 Feb 21
Pulse Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
4:18pm
424B5
9flieou5lfz hxf1q02z
4 Feb 21
Prospectus supplement for primary offering
8:46am
8-K
EX-99.1
n59bw w02g812npgswu
4 Feb 21
Pulse Biosciences, Inc. Announces At-The-Market Equity Offering Program
8:30am
8-K
EX-1.1
9vql5d5wy4
4 Feb 21
Pulse Biosciences, Inc. Announces At-The-Market Equity Offering Program
8:30am
8-K
EX-99.1
03dx cea7gpbgw
3 Feb 21
Pulse Biosciences Announces FDA Clearance for the CellFX® System
4:13pm
8-K
EX-99.1
fgq47 h34r7
25 Jan 21
Pulse Biosciences Announces CE Mark Approval for CellFX® System
8:12am
8-K
EX-99.1
5pfevobbuu
5 Jan 21
Pulse Biosciences, Inc. Announces Redemption of Warrants
9:16am
8-K
EX-99.1
ds2y6
9 Nov 20
Pulse Biosciences Reports Third Quarter 2020 Financial Results
4:29pm
8-K
EX-99.1
6p0dk1effzm
10 Aug 20
Pulse Biosciences Reports Second Quarter 2020 Financial Results
4:27pm